Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AMRX | Amneal Pharmaceuticals, Inc. | Executive Vice President & CFO | $4.72M | Mar 12, 2024 | ||
KDMN | Kadmon Holdings, Inc. | Director | Nov 9, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|